Catalyst Crew Technologies Corp. (OTC: CCTC), a digital health and artificial intelligence technology company, announced that its Chief Executive Officer, Dr. Kevin Rodan Levy, plans to attend HLTH Europe 2026, an international healthcare conference scheduled for June 15-18 in Amsterdam. The conference focuses on digital health, healthcare innovation, and emerging technologies.
Dr. Levy's attendance is intended to support the Company's broader strategic initiatives, including engagement with healthcare industry participants, evaluation of emerging technologies and market developments, and exploration of strategic relationships that may support the continued development and expansion of the Company's evolving digital health ecosystem.
The Company believes that attendance at major international healthcare conferences may provide valuable opportunities to observe industry developments, strengthen professional networks, and support its broader efforts to advance its telehealth and artificial intelligence healthcare platform strategy. HLTH Europe is expected to convene healthcare executives, innovators, investors, and technology leaders from across global markets to discuss healthcare transformation, digital infrastructure, and advancements in healthcare delivery.
Dr. Levy stated: “As we continue advancing our digital health and artificial intelligence initiatives, attending major international healthcare events provides valuable opportunities to observe emerging industry trends, engage with healthcare innovators, and further strengthen our long-term strategic positioning.”
The Company continues to advance the development of its telehealth platform infrastructure, artificial intelligence healthcare modules, and broader digital health strategy across Latin America and emerging markets. More information is available at https://catalystcrewai.com or in the Company’s filings with the U.S. Securities and Exchange Commission at www.sec.gov.
This announcement underscores Catalyst Crew's commitment to expanding its presence in the digital health sector and leveraging international platforms to drive innovation in emerging markets. The company is an artificial intelligence-driven healthcare technology company focused on developing scalable digital health solutions for emerging markets, with an initial emphasis on Latin America. Through technology development initiatives, strategic partnerships, and targeted acquisitions, CCTC is building an integrated healthcare technology platform positioned to address the growing demand for modernized healthcare delivery systems across emerging markets.
